XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	6,470	6,480	10:31
	6,470	6,480	09:27

Realtime

Geld

Brief

Zeit

6,470

6,480

10:31

6,470

6,480

09:27

XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025

Das Instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025
The instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY is traded cum capital adjustment on 06.11.2025 and ex capital adjustment on 07.11.2025

Das Instrument ZR8 FR001400CM63 ONCODES.PREC.MED. EO-,34 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025
The instrument ZR8 FR001400CM63 ONCODES.PREC.MED. EO-,34 EQUITY is traded cum capital adjustment on 06.11.2025 and ex capital adjustment on 07.11.2025

Das Instrument DHG IE00BJMZDW83 DALATA HOTEL GROUP EO-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025
The instrument DHG IE00BJMZDW83 DALATA HOTEL GROUP EO-,01 EQUITY is traded cum capital adjustment on 06.11.2025 and ex capital adjustment on 07.11.2025

Das Instrument FPO BMG702782084 PETRA DIAMONDS LS-,0005 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025
The instrument FPO BMG702782084 PETRA DIAMONDS LS-,0005 EQUITY is traded cum capital adjustment on 06.11.2025 and ex capital adjustment on 07.11.2025

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025	Das Instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025 The instrument ZC0 NO0012780958 STAINL.TANKERS NK... ► Artikel lesen
Mi	Trium Capital LLP discloses 1.17% position in Dalata Hotel Group
Mi	Trium Capital meldet Beteiligung von 1,17 % an der Dalata Hotel Group
Mi	Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc	DJ Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc 05-Nov-2025 / 15:04 GMT/BST =----------------------------------------------------------------------------------------------------------------------... ► Artikel lesen
Mi	Dalata Hotel Group PLC: HOL-Holding(s) in Company	DJ Dalata Hotel Group PLC: HOL-Holding(s) in Company Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: HOL-Holding(s) in Company 05-Nov-2025 / 14:05 GMT/BST =----------------------------------------------------------------------------------------------------------------------... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025

Trium Capital LLP discloses 1.17% position in Dalata Hotel Group

Trium Capital meldet Beteiligung von 1,17 % an der Dalata Hotel Group

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc

DJ Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc 05-Nov-2025 / 15:04 GMT/BST =----------------------------------------------------------------------------------------------------------------------...
► Artikel lesen

Dalata Hotel Group PLC: HOL-Holding(s) in Company

DJ Dalata Hotel Group PLC: HOL-Holding(s) in Company Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: HOL-Holding(s) in Company 05-Nov-2025 / 14:05 GMT/BST =----------------------------------------------------------------------------------------------------------------------...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025	Das Instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025 The instrument ZC0 NO0012780958 STAINL.TANKERS NK... ► Artikel lesen
14.10.	Oncodesign Precision Medicine: OPM Obtains Development Grants From the Bourgogne Franche-Comté Region	Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic... ► Artikel lesen
09.10.	Oncodesign Precision Medicine: OPM Publishes Its 2025 Half-Yearly Report	Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic... ► Artikel lesen
25.09.	Oncodesign Precision Medicine: OPM Integrated Into the LRRK2 Investigative Therapeutics Exchange Program From the Michael J. Fox Foundation for Parkinson's Research	OPM will contribute its unique expertise in kinase inhibitor development and its Nanocyclix®-derived compound OPM-201 to the LITE program OPM will leverage the LITE consortium to accelerate... ► Artikel lesen
31.07.	Oncodesign Precision Medicine: OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position	The REVERT Phase 1b/2a clinical trial evaluating OPM-101 in patients with advanced melanoma resistant to anti-PD1 has been submitted to the Swiss regulatory (Swissmedic) and ethics (Swiss ethics)... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025

14.10.

Oncodesign Precision Medicine: OPM Obtains Development Grants From the Bourgogne Franche-Comté Region

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic...
► Artikel lesen

09.10.

Oncodesign Precision Medicine: OPM Publishes Its 2025 Half-Yearly Report

25.09.

Oncodesign Precision Medicine: OPM Integrated Into the LRRK2 Investigative Therapeutics Exchange Program From the Michael J. Fox Foundation for Parkinson's Research

OPM will contribute its unique expertise in kinase inhibitor development and its Nanocyclix®-derived compound OPM-201 to the LITE program OPM will leverage the LITE consortium to accelerate...
► Artikel lesen

31.07.

Oncodesign Precision Medicine: OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position

The REVERT Phase 1b/2a clinical trial evaluating OPM-101 in patients with advanced melanoma resistant to anti-PD1 has been submitted to the Swiss regulatory (Swissmedic) and ethics (Swiss ethics)...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025	Das Instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025 The instrument ZC0 NO0012780958 STAINL.TANKERS NK... ► Artikel lesen
Fr	Petra Diamonds Ltd - Notice of AGM	Petra Diamonds Ltd - Notice of AGM PR Newswire LONDON, United Kingdom, October 31 FOR IMMEDIATE RELEASE. ... ► Artikel lesen
29.10.	Petra achieves solid first-quarter performance: London-listed Petra Diamonds, which owns and operates the Cullinan and Finsch ...
29.10.	Petra Diamonds Ltd - Q1 FY 2026 Operating Update	Petra Diamonds Ltd - Q1 FY 2026 Operating Update PR Newswire LONDON, United Kingdom, October 29 ... ► Artikel lesen
24.10.	Petra Diamonds corrects error in annual report on warrant plan

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025

Petra Diamonds Ltd - Notice of AGM

Petra Diamonds Ltd - Notice of AGM PR Newswire LONDON, United Kingdom, October 31 FOR IMMEDIATE RELEASE. ...
► Artikel lesen

29.10.

Petra achieves solid first-quarter performance: London-listed Petra Diamonds, which owns and operates the Cullinan and Finsch ...

29.10.

Petra Diamonds Ltd - Q1 FY 2026 Operating Update

Petra Diamonds Ltd - Q1 FY 2026 Operating Update PR Newswire LONDON, United Kingdom, October 29 ...
► Artikel lesen

24.10.

Petra Diamonds corrects error in annual report on warrant plan

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025	Das Instrument ZC0 NO0012780958 STAINL.TANKERS NK 10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.11.2025 und ex Kapitalmassnahme am 07.11.2025 The instrument ZC0 NO0012780958 STAINL.TANKERS NK... ► Artikel lesen
Mi	Stainless Tankers ASA: Stainless Tankers announces financial results for the three months ended September 30, 2025.
10.09.	Stainless Tankers ASA: Stainless Tankers - Settlement of warrants
01.09.	Stainless Tankers ASA: Stainless Tankers - Ex. dividend of USD 0.335 per share today
01.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 01.09.2025	Das Instrument CN5 US5537453087 MSP REC. CL.A DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 01.09.2025 und ex Kapitalmassnahme am 02.09.2025 The instrument CN5 US5537453087 MSP REC. CL.A DL-... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 06.11.2025

Stainless Tankers ASA: Stainless Tankers announces financial results for the three months ended September 30, 2025.

10.09.

Stainless Tankers ASA: Stainless Tankers - Settlement of warrants

01.09.

Stainless Tankers ASA: Stainless Tankers - Ex. dividend of USD 0.335 per share today

01.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 01.09.2025

Das Instrument CN5 US5537453087 MSP REC. CL.A DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 01.09.2025 und ex Kapitalmassnahme am 02.09.2025 The instrument CN5 US5537453087 MSP REC. CL.A DL-...
► Artikel lesen